MWF/ZtmRrrc |
glomerular capillary ultrafiltration coefficient |
enalapril (50 mg/l) (for 60 days) |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
glomerular filtration trait |
male |
126 days
| 10 |
0.13 |
nl/(s x mmHg) |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
100982 |
2541 |
WKY |
glomerular capillary ultrafiltration coefficient |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 8 |
0.09 |
nl/(s x mmHg) |
0.01 |
0.03 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
|
0 |
|
kf |
100589 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
0.16 |
nl/(s x mmHg) |
0.05 |
0.1 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100617 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
0.9% sodium chloride solution (3 ml) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 9 |
0.07 |
nl/(s x mmHg) |
0.01 |
0.04 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
|
0 |
|
kf |
100587 |
2479 |
MWF/ZtmRrrc |
glomerular capillary ultrafiltration coefficient |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
glomerular filtration trait |
male |
126 days
| 8 |
0.06 |
nl/(s x mmHg) |
0.01 |
0.02 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
|
0 |
|
|
100981 |
2541 |
WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 6 |
0.02 |
nl/(s x mmHg) |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
15 |
days |
kf |
100588 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
0.06 |
nl/(s x mmHg) |
0.02 |
0.04 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100616 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 9 |
0.04 |
nl/(s x mmHg) |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100590 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 8 |
0.11 |
nl/(s x mmHg) |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100591 |
2479 |